相关实验视频

Updated: Jun 10, 2025

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

在症状与无症状动脉样硬化疾病的血管PET成像中F-NaF的摄取:元分析

Shiv Bhakta¹, Mohammed M Chowdhury², Jason M Tarkin³

¹Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Vascular medicine (London, England)

|October 17, 2024

概括

18F-化 (NaF) PET成像检测到个体内的动脉样硬化斑块中的微化差异,表明有症状的疾病. 为了将其用作风险分层工具,需要进一步标准化.

科学领域:

心血管成像 - 心血管成像
核医学就是核医学.
动脉样硬化研究动脉样硬化研究

背景情况:

18F-化 (NaF) 阳离子发射断层扫描 (PET) 正在出现,用于在动脉样硬化中进行体内微化评估.
纳氧化的摄入与高风险斑块特征和临床结果相关.
了解NaF摄入与症状与无症状疾病的关系至关重要.

研究的目的:

为了对18F-NaF PET成像采集进行元分析.
评估NaF吸收和症状与无症状动脉样硬化疾病之间的关系.

主要方法:

按照PRISMA指南进行系统审查和元分析.
在多个数据库 (MEDLINE,Embase,PubMed等) 进行了搜索. 在2024年5月之前.
包括测量动脉样硬化斑块中18F-NaF吸收的研究,分析症状与无症状疾病.

主要成果:

分析了16项涉及423名参与者的研究.
在同一个体内的症状和无症状斑块之间发现了显著的NaF吸收差异 (平均差异为0.43,p < 0.0001).
不同个体的症状和无症状斑块之间没有观察到NaF吸收的显著差异 (平均差异为0.27,p = 0.28).

结论:

18F-NaF PET可以在个体内区分症状与无症状斑块中的微化.
这表明NaF PET是症状性动脉样硬化疾病的标志物.
需要进一步的研究来规范风险分层和结果测量的协议.

关键词:

动脉样硬化动脉样硬化在微化过程中,微化定子发射断层扫描 (PET) 是一种风险分层的风险分层.血管成像/诊断血管成像/诊断

更多相关视频

Author Spotlight: Enhanced Quantification of Cardiovascular Calcification Progression for Longitudinal Micro PET/CT Studies in Small Research Animals

Author Spotlight: Enhanced Quantification of Cardiovascular Calcification Progression for Longitudinal Micro PET/CT Studies in Small Research Animals

Published on: November 15, 2024

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...